Cardiovascular Complications in Patients With Hypertension: A Retrospective Study
DOI:
https://doi.org/10.69980/ajpr.v28i5.450Keywords:
Hypertension, cardiovascular complications, stroke, diabetes mellitus, risk factors, retrospective studyAbstract
Background: Hypertension is a leading global contributor to cardiovascular morbidity and mortality, with complications often resulting in stroke, myocardial infarction, and heart failure. This study assesses the prevalence and predictors of cardiovascular events among hypertensive patients over a five-year period.
Methods: A retrospective cohort study was conducted on 500 adult hypertensive patients from 2018 to 2023. Patients with prior cardiovascular disease were excluded. Data were extracted from electronic medical records, including demographics, comorbidities, smoking history, BMI, and cardiovascular complications. Statistical analyses involved chi-square tests and logistic regression to identify significant predictors of events.
Results: Cardiovascular complications occurred in 196 patients (39.2%), with stroke (18.4%) as the most common outcome, followed by heart failure (15.2%) and myocardial infarction (12.2%). Age ≥65 years (OR = 2.31; 95% CI: 1.51–3.54) and diabetes mellitus (OR = 2.84; 95% CI: 1.91–4.21) were strong independent predictors. Male sex modestly increased risk (OR = 1.62; p = .041). Smoking and obesity showed non-significant trends toward increased complications. Subgroup analysis indicated diabetic hypertensives were more prone to stroke and heart failure.
Conclusion: A substantial proportion of hypertensive patients develop cardiovascular complications, particularly those who are older or diabetic. Targeted interventions focusing on age and metabolic risk modification are critical to reducing disease burden in this population.
References
1. Wu S, Xu Y, Zheng R, et al. Hypertension defined by 2017 ACC/AHA guideline, ideal cardiovascular health metrics, and risk of cardiovascular disease: a nationwide prospective cohort study. Lancet Reg Health West Pac. 2022;20:100370.
2. Bain W. The causes and treatment of high blood-pressure. Proc R Soc Med. 1912;5(Ther _Pharmacol):43–54.
3. Zhou B, Bentham J, Di Cesare M, et al. Worldwide trends in blood pressure from 1975 to 2015. Lancet. 2017;389(10064):37–55.
4. Kifle ZD, Adugna M, Chanie GS, et al. Prevalence and associated factors of hypertension complications. Clin Epidemiol Glob Health. 2022;13:100951.
5. Zhou B, Carrillo-Larco RM, Danaei G, et al. Global hypertension trends 1990–2019. Lancet. 2021;398(10304):957–980.
6. Huang QF, Yang WY, Asayama K, et al. Ambulatory blood pressure monitoring in hypertension. Hypertension. 2021;77(2):254–264.
7. Constanti M, Boffa R, Floyd CN, et al. Diagnosis of hypertension in primary care. J Hum Hypertens. 2021;35(5):455–461.
8. Zinat Motlagh SF, Chaman R, Ghafari SR, et al. Hypertension knowledge and control in Southern Iran. Int J Hypertens. 2015;2015:897070.
9. Tasić I, Kostić S, Stojanović NM, et al. Predictors of cardiovascular events in hypertensive patients. Medicina. 2020;56(4):182.
10. Gnilo MR, Gonzales E. ASCVD risk stratification of hypertensive adults. J Hypertens. 2023;41(Suppl 1):e507.
11. Talle MA, Ngarande E, Doubell AF, et al. Cardiac complications of hypertensive emergency. J Cardiovasc Dev Dis. 2022;9(8):276.
12. Lauder L, Mahfoud F, Azizi M, et al. Hypertension management in comorbid patients. Eur Heart J. 2023;44(23):2066–2077.
13. Gupta R, Guptha S. Strategies for initial hypertension management. Indian J Med Res. 2010;132(5):531–542.
14. Thomopoulos C, Parati G, Zanchetti A. Antihypertensive drugs in younger vs older adults. J Hypertens. 2018;36(8):1637–1647.
15. Emerging Risk Factors Collaboration. Diabetes and vascular disease risk. Lancet. 2010;375 (9733):2215–2222.
16. Rask-Madsen C, King GL. Mechanisms of vascular injury in diabetes. Cell Metab. 2013;17(1):20–33. PMID: 29459239
17. Wakili R, Voigt N, Kaestner F, et al. Atrial remodeling in diabetes. Cardiovasc Res. 2022;118(5):1028–1042. PMID: 36231118
18. Lakatta EG, Levy D. Arterial and cardiac aging. Circulation. 2003;107(1):139–146.
19. North BJ, Sinclair DA. Aging and cardiovascular disease. Circ Res. 2012;110(8):1097–1108.
20. Huang L, Zhang Y, Chen X, et al. Aging and ventricular remodeling in hypertension. Hypertens Res. 2023;46(5):431–439. PMID: 37414864
21. Mosca L, Barrett-Connor E, Wenger NK. Sex differences in cardiovascular prevention. Circulation. 2011;124(19):2145–2154.
22. Kim JH, Kim H, Park J, et al. Sex differences in hypertensive complications. Hypertens Res. 2021;44(6):737–745. PMID: 32567334
23. Lavie CJ, De Schutter A, Milani RV. The obesity paradox. Nat Rev Endocrinol. 2015;11(1):55–62.
24. U.S. Department of Health and Human Services. The health consequences of smoking: 50 years of progress. Washington, DC: HHS; 2014.
25. Fudim M, Frahm K, Patel CB, et al. Diastolic dysfunction and diabetes. Curr Heart Fail Rep. 2018;15(4):276–284. PMID: 29429751
26. Gulel O, Gulel H, Demir K, et al. Hyperglycemia and vascular complications. Exp Clin Endocrinol Diabetes. 2020;128(8):525–530. PMID: 329666 90
27. Liu L, Zhang T, Yang W, et al. Metabolic syndrome in hypertensive patients. J Clin Hypertens. 2024;26(1):89–98. PMID: 39541433
28. Bombardini T, Picano E, Salvadori S, et al. Endothelial function in hypertension. Eur Heart J Cardiovasc Imaging. 2022;23(8):1046–1054. PMID: 35869979
29. Lloyd-Jones DM, Larson MG, Beiser A, et al. Lifetime coronary heart disease risk. N Engl J Med. 2002;346(1):10–15.
30. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA guidelines on hypertension. Hypertension. 2018;71(6):e13–e115.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 American Journal of Psychiatric Rehabilitation
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License permitting all use, distribution, and reproduction in any medium, provided the work is properly cited.
